Alexandria Real Estate Equities
ARE
$119.27
Share price
-0.18%
Change (1 day)
-3.85%
Change (1 year)
Categories
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.
Alexandria Real Estate Equities (ARE) - Total assets
Total assets on the balance sheet as of December 2023 : $36.77 B
According to Alexandria Real Estate Equities 's latest financial reports the company's total assets are $36.77 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Alexandria Real Estate Equities - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $36.77 B | 3.51% |
| 2022-12-31 | $35.52 B | 17.55% |
| 2021-12-31 | $30.21 B | 32.38% |
| 2020-12-31 | $22.82 B | 24.13% |
| 2019-12-31 | $18.39 B | 27.14% |
| 2018-12-31 | $14.46 B | 19.51% |
| 2017-12-31 | $12.10 B | 16.89% |
| 2016-12-31 | $10.35 B | 16.6% |
| 2015-12-31 | $8.88 B | 9.16% |
| 2014-12-31 | $8.13 B | 8.05% |
| 2013-12-31 | $7.52 B | 5.31% |
| 2012-12-31 | $7.15 B | 8.76% |
| 2011-12-31 | $6.57 B | 11.32% |
| 2010-12-31 | $5.90 B | 8.22% |
| 2009-12-31 | $5.45 B | 6.34% |
| 2008-12-31 | $5.13 B | 10.56% |
| 2007-12-31 | $4.64 B | 28.32% |
| 2006-12-31 | $3.61 B | 53.12% |
| 2005-12-31 | $2.36 B | 26.18% |
| 2004-12-31 | $1.87 B | 47.13% |
| 2003-12-31 | $1.27 B | 9.78% |
| 2002-12-31 | $1.15 B | 20.49% |
| 2001-12-31 | $0.96 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 515.97% | 🇺🇸 USA |
 Eli Lilly LLY | $64.00 B | 74.07% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 164.21% | 🇺🇸 USA |
 Gilead Sciences GILD | $62.12 B | 68.95% | 🇺🇸 USA |
 Illumina ILMN | $10.11 B | -72.50% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $95.15 B | 158.79% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $3.82 B | -89.58% | 🇺🇸 USA |